Agilent and Lam Research participated in a $30m round for UCSF's DNA analysis spinout, Mission Bio, whose existing shareholders include Stanford-StartX Fund.
Mission Bio, a US-based DNA analysis spinout of University of California, San Francisco, secured $30m yesterday in a series B round backed by scientific diagnostics firm Agilent Technologies.
Lam Research Capital, the corporate venturing arm of semiconductor manufacturing equipment supplier Lam Research, also injected funding, alongside investment firm Cota Capital and venture capital firm Mayfield Fund.
Founded in 2014, Mission Bio has built a genomics analytics platform called Tapestri to perform DNA sequencing analysis on thousands of cells while distinguishing…